Free 5-minute assessment finds drug supply chain gaps before the FDA does. Built for med spas, dermatology, ophthalmology, and optometry.
We pride ourselves on running a compliant practice, Claritas Axis FDA Readiness Snapshot still found three documentation gaps we hadn’t recognized. It took five minutes and changed how we operate.”
— Jerri Hirst, Owner, JKH Aesthetics; Host, The Beauty Outlaw Podcast
VENICE, FL, UNITED STATES, April 1, 2026 /EINPresswire.com/ -- Claritas Axis today announced the launch of the FDA Compliance Readiness Snapshot at a time when federal and state regulators are actively inspecting physician-owned practices for drug supply chain documentation failures issuing citations, fines, license suspensions, and permanent revocations when required records cannot be produced.
The launch comes weeks before the FDA takes the main stage at the American Med Spa
The Claritas Axis FDA Compliance Readiness Snapshot is the answer a free, ten-question weighted assessment that evaluates a physician-owned practice against the same documentation areas federal and state regulators review, delivering an instant risk score in under five minutes with no account creation, no sales call, and no prior compliance knowledge required.
AN ENFORCEMENT ENVIRONMENT THAT HAS REACHED THE EXAM LANE
In January 2026, the FDA issued its first Form 483 against a physician-owned med spa in Texas, citing failures in how Rx drugs were purchased, tracked, and documented. Investigators cross-referenced manufacturer shipment data against purchase records and administration logs identifying volume discrepancies, unlabeled product, and missing vendor authorization documentation.
States are moving in parallel. A New York statewide sweep of 223 med spa businesses resulted in 87 practices cited for violations including expired and counterfeit drug products and unauthorized vendors with outcomes ranging from monetary fines to license suspensions and permanent revocations.
In June 2025, the FDA finalized its Remote Regulatory Assessment framework, making remote records requests a permanent enforcement tool. An inspection can now effectively begin before an investigator appears at the front desk.
These enforcement actions fall under the Drug Supply Chain Security Act (DSCSA), enacted in 2013 and now applied at the physician practice level for the first time. The law requires practices that purchase and administer Rx drugs in-office to maintain documented trading partner verification, purchase records, and product traceability requirements most physician-owned practices have never been asked to meet.
"Most practices that fail these inspections don't fail because of intent. They fail because they have never been asked to produce this documentation before."
— James Strafuss, Founder, Claritas Axis
CLARITAS AXIS FDA COMPLIANCE READINESS SNAPSHOT
The Readiness Snapshot evaluates a practice against the same documentation areas regulators review, with each section weighted by enforcement priority. Results are delivered instantly as Low Risk, Moderate Exposure, or High / Critical Exposure giving owners and administrators a clear starting point for remediation. No account creation. No sales call. Under five minutes.
Practices with significant gaps can access the Full Readiness Assessment for $99 covering all ten FDA-evaluated operational areas with an instant, practice-specific gap report. Full platform pricing at claritasaxis.com.
"The awareness gap in this market is significant. We built the Readiness Snapshot so any practice regardless of size or resources can get an honest picture of their exposure in the time it takes to answer ten questions."
— James Strafuss, Founder, Claritas Axis
TARGET MARKETS
Designed for any physician-owned practice purchasing and administering Rx drugs in-office. Claritas Axis currently focuses on med spas and aesthetics practices, where recent enforcement actions establish the most immediate exposure, and also serves ophthalmology, optometry, dermatology, oncology, rheumatology, and medically integrated dispensary practices where Rx drug documentation requirements are equally applicable and compliance gaps equally common.
INDUSTRY RESPONSE
"This is not a niche compliance issue it is critical information for every practice administering prescription drug products, and the solution Claritas has built is exactly what this industry needs right now."
— Clay Daniells, CEO, QooQoo; Marketing firm serving the aesthetics and eyecare industries
ABOUT CLARITAS AXIS
Claritas Axis is an FDA drug supply chain compliance platform for physician-owned medical practices, providing self-serve assessment tools, practice-specific documentation, expert interpretation, staff training, and live inspection support. Find the gaps before the FDA does. claritasaxis.com · James@claritasaxis.com · 12161 Mercado Drive, Ste 128, Venice, FL 34293
Claritas Axis is not affiliated with or endorsed by the U.S. Food and Drug Administration
No comments:
Post a Comment